Piceatannol Inhibits TNF-Induced NF-κB Activation and NF-κB-Mediated Gene Expression Through Suppression of IκBα Kinase and p65 Phosphorylation
- 1 December 2002
- journal article
- Published by The American Association of Immunologists
- Vol. 169 (11), 6490-6497
- https://doi.org/10.4049/jimmunol.169.11.6490
Abstract
Piceatannol is an anti-inflammatory, immunomodulatory, and anti-proliferative stilbene that has been shown to interfere with the cytokine signaling pathway. Previously, we have shown that resveratrol suppresses the activation of the nuclear transcription factor NF-κB. Piceatannol, previously reported as a selective inhibitor of protein tyrosine kinase Syk, is structurally homologous to resveratrol. Whether piceatannol can also suppress NF-κB activation was investigated. The treatment of human myeloid cells with piceatannol suppressed TNF-induced DNA binding activity of NF-κB. In contrast, stilbene or rhaponticin (another analog of piceatannol) had no effect, suggesting the critical role of hydroxyl groups. The effect of piceatannol was not restricted to myeloid cells, as TNF-induced NF-κB activation was also suppressed in lymphocyte and epithelial cells. Piceatannol also inhibited NF-κB activated by H2O2, PMA, LPS, okadaic acid, and ceramide. Piceatannol abrogated the expression of TNF-induced NF-κB-dependent reporter gene and of matrix metalloprotease-9, cyclooxygenase-2, and cyclin D1. When examined for the mechanism, we found that piceatannol inhibited TNF-induced IκBα phosphorylation, p65 phosphorylation, p65 nuclear translocation, and IκBα kinase activation, but had no significant effect on IκBα degradation. Piceatannol inhibited NF-κB in cells with deleted Syk, indicating the lack of involvement of this kinase. Overall, our results clearly demonstrate that hydroxyl groups of stilbenes are critical and that piceatannol, a tetrahydroxystilbene, suppresses NF-κB activation induced by various inflammatory agents through inhibition of IκBα kinase and p65 phosphorylation.Keywords
This publication has 37 references indexed in Scilit:
- Nuclear Factor-κB Activation: A Question of Life or DeathBMB Reports, 2002
- Biological Effects of ResveratrolAntioxidants and Redox Signaling, 2001
- Role of Nuclear Factor‐Kappa B (NF‐κB) in Inflammation, Periodontitis, and AtherogenesisAnnals of Periodontology, 2001
- Distinct Mechanisms of STAT Phosphorylation via the Interferon-α/β ReceptorJournal of Biological Chemistry, 2000
- Pervanadate-induced Nuclear Factor-κB Activation Requires Tyrosine Phosphorylation and Degradation of IκBαPublished by Elsevier BV ,2000
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Activation of NF-κB by RANK Requires Tumor Necrosis Factor Receptor-associated Factor (TRAF) 6 and NF-κB-inducing KinasePublished by Elsevier BV ,1999
- Inhibition of Eukaryote Serine/Threonine-Specific Protein Kinases by PiceatannolPlanta Medica, 1998
- Syk Mutation in Jurkat E6-derived Clones Results in Lack of p72syk ExpressionPublished by Elsevier BV ,1995
- Piceatannol (3,4,3′,5′-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitorBiochemical and Biophysical Research Communications, 1989